CLOSE X

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1312.50-39.35 (-2.91 %)
PREV CLOSE ( ) 1351.85
OPEN PRICE ( ) 1351.95
BID PRICE (QTY) 1312.65 (13)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 126785
TODAY'S LOW / HIGH ( )1310.85 1352.00
52 WK LOW / HIGH ( )1283 1672.2
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 17-08 1935
Management Info
Y K Hamied - Chairman Umang Vohra - Managing Director
Registered Office

Address Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone 022-24826000

Email contactus@cipla.com

Website www.cipla.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, Luxembourg
NEWS
11Feb Cipla’s arm receives two inspectional
Cipla’s wholly owned subsidiary -- InvaGen Pharmaceuticals, Inc. (InvaGe..
11Feb Cipla gains despite its arm receives t
Cipla is currently trading at Rs. 1347.65, up by 5.55 points or 0.41% fr..
10Feb Cipla informs about updates
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
02Feb Cipla informs about appointment of sen
Pursuant to Regulation 30 of the SEBI Listing Regulations, Cipla has inf..
23Jan Cipla's consolidated net profit drops
Cipla has reported results for third quarter ended December 31, 2025 (Q3..
Financials
Rs. in Millions
QTR Dec 25 ANNUAL 25
Net Profit6168.8000000000151576.5
Gross Profit 7361.70000000001 64688.2
Operating Profit 1137967631.6
Net Sales 44980.8190448.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 27729.05 (3.36%)
M.Cap ( in Cr)59128.31
Bharat Parenterals (BSE)
 1149.00 (5.41%)
M.Cap ( in Cr)775.00
Venus Remedies (BSE)
 682.90 (4.96%)
M.Cap ( in Cr)902.14
Emcure Pharma (BSE)
 1474.55 (1.98%)
M.Cap ( in Cr)27869.66
Concord Biotech (BSE)
 1223.60 (2.04%)
M.Cap ( in Cr)12543.48
Shareholding Pattern
PROMOTERS 29.21%
MUTUAL FUNDS/UTI 19.21%
NON-INSTITUTION 16.14%
FI/BANKS/INSURANCE 9.62%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data December 2025 Broking Complaints Data December 2025 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.